Trial record 29 of 57 for:    leukemia AND portland | United States, Oregon | Phase 2 | NIH

Validation of an in Vitro Assay to Predict Targeted Therapies for Acute Leukemia Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2015 by OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Bristol-Myers Squibb
Information provided by (Responsible Party):
OHSU Knight Cancer Institute Identifier:
First received: June 13, 2012
Last updated: October 14, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)